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Abstract: Advances in spectral deconvolution technologies are rapidly enabling researchers
to replace or enhance traditional epiﬂuorescence microscopes with instruments capable of
detecting numerous markers simultaneously in a multiplexed fashion. While signiﬁcantly
expediting sample throughput and elucidating sample information, this technology is limited
by the spectral width of common ﬂuorescence reporters. Semiconductor nanocrystals (NC’s)
are very bright, narrow band ﬂuorescence emitters with great potential for multiplexed
ﬂuorescence detection, however the availability of NC’s with facile attachment chemistries
to targeting molecules has been a severe limitation to the advancement of NC technology
in applications such as immunocytochemistry and immunohistochemistry. Here we report
the development of simple, yet novel attachment chemistries for antibodies onto NC’s and
demonstrate how spectral deconvolution technology enables the multiplexed detection of
5 distinct NC-antibody conjugates with ﬂuorescence emission wavelengths separated by as
little as 20 nm.
Keywords: quantum dot; nanocrystal; IHC; immunohistochemistry; spectral imaging;
multiplexing; conjugation; antibodySensors 2011, 11 10558
1. Introduction
Immunohistochemistry (IHC), or the immunological staining and detection of cellular markers in
tissue, is a mainstay technique in pathology and diagnostics research and is the current recipient of
several new advances in technology; advances which may be capable of evolving IHC from its roots in
limited colorimetric staining to a multiplexed ﬂuorescence-based method capable of imaging multiple
target antigens within a single tissue section. Quantum dot nanocrystal (NC) ﬂuorescent markers in
combination with multispectral imaging (MSI) technology has been a particularly exciting union that
has resulted in a respectable number of promising studies over the past few years [1–8].
Quantum dot NC’s are semiconductor particles with dimensions in the 1–10 nm size regime and
which exhibit a host of favorable optical properties that make them ideally suited for molecular
detection. In particular, NC’s boast narrow, Gaussian-shaped emission spectra notably absent of
red-tailing, broad excitation spectra that increase toward the ultraviolet, extinction coefﬁcients and
quantum efﬁciencies which are both impressively high, and a tenacious resistance to photobleaching
even under intense excitation [9–13]. When used as a ﬂuorescent probe bound to antigen-derived
markers such as IgG antibodies (Ab), NC’s have demonstrated their rather unique utility for multiplexed
detection [3,6,7,13–15] and their further potential for antigen quantiﬁcation [5,8,16,17], proposing
a solid alternative to the more traditional but limiting two and three step immunostaining. Thus,
NC’s represent a technology capable of reducing sample number and preparation requirements, while
simultaneously elucidating more complex cell-cell interactions, protein localization and expression
patterns [3]. Despite the many favorable optical properties of NC’s, as a ﬂuorescence-based method
in which tissue is the substrate (IHC, in vivo imaging, etc.) they must yet overcome endogenous
autoﬂuorescence associated with tissue sections [2].
The advent of MSI technology has speciﬁcally addressed the difﬁculties surrounding the detection of
multiplexed ﬂuorescent markers from the prevalence of background autoﬂuorescence. Multispectral
imaging cameras, which may be mounted to a standard camera port on a ﬂuorescent microscope,
are capable of replacing individual emission ﬁlters optimized to detect one ﬂuorophore each, with
a single tunable liquid crystal ﬁlter able to detect multiple ﬂuorophores with wavelength resolution
down to 3 nm. By creating “spectral libraries” of all involved ﬂuorophores from control samples,
the accompanying software is capable of detecting and deconvoluting ﬂuorescence proﬁles for each
ﬂuorophore involved on a per pixel basis, thus delivering a high resolution image in which each pixel’s
spectrum has been measured and background-subtracted [2]. Therefore, the relationship between NC’s
and MSI technologies seems naturally symbiotic, where the antibody-conjugated NC’s provide stable,
bright, narrow emission proﬁles with biological signiﬁcance, and MSI provides hardware and software
capable of detecting and deconvoluting individual signals to reconstruct a meaningful image. The real
challenge to achieving high quality images of a tissue sample lies in the particular details of producing
the Ab-NC conjugate (conjugation chemistry and format) and the staining protocol (sequential addition
or cocktail formulation). Conjugation and staining parameters are capable of dictating either the success
or failure of this endeavor.
Although previous reports on the use of NC’s in IHC have been successful in demonstrating the
range of 2-plex to 5-plex colorimetric multiplexed staining, achieving these goals required either customSensors 2011, 11 10559
modiﬁcation of the NC surface [17], unique, sequential staining methods [3,5], or the use of NC
conjugates as secondary reagents [6,8,16,18,19], all of which contribute additional complexity and time
totheoverallprocess. TosuccessfullyimplementthemainstreamuseofﬂuorescentNCmarkersintoIHC
across multiple disciplines such as cancer biology, immunology, and pathology will require a simple,
robust procedure for producing Ab-NC conjugates coupled with standard staining techniques which can
be applied in a facile yet rapid manner. In this report, we present two simplistic conjugation chemistries
that enable expedient NC conjugation to monoclonal antibodies in combination with optimized staining
techniques that allow a simultaneous cocktail-style protocol for multiplexed antigen detection.
2. Experimental
2.1. Materials
All monoclonal antibodies were grown in-house from either tissue culture hybridoma or mouse
ascites and puriﬁed over protein G afﬁnity column. 100 kDa and 30 kDa molecular weight cutoff
concentrators were purchased from Millipore, and desalting spin columns were purchased from
Princeton Separations (CS-800). n-hydroxysuccinimidyl ester 6-hydrazinonicotinamide (S-HyNic) and
4-formylbenzide (4FB) were obtained from Solulink, and phospholipids (1,2-distearoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (mPEG)) were purchased from Avanti
Polar Lipids. 2-Mercaptoethanol (2-Me), aniline, and sulfobenzaldehyde were purchased from
Sigma-Aldrich.
2.2. Nanocrystal Synthesis and Modiﬁcation
The eFluor CdSe/ZnS core/shell NC’s were synthesized using standard high temperature reactions
by injection of organometallic precursors into hot coordinating solvents [20–22], with ﬁnal
photoluminescence (PL) emission wavelengths centered near 525, 565, 605, 625, and 650 nm.
The nanocrystals were then dispersed into phospholipid micelles using established techniques [23].
Maleimido-activation and 4FB-modiﬁcation of the lipid layers were performed using proprietary
methods and the phospholipid micelle-encapsulated NC’s were then either lyophilized to dryness
(maleimide NC’s) or stored in the refrigerator (4FB-NC’s) at 4 C until use.
2.3. Amine-Reactive Chemistry
The amine-reactive chemistry utilizes a bioorthogonal ligation reaction targeting available primary
amine groups on the biomolecule and a complementary molecule on pre-activated NC’s. Figure 1(C)
describes the process by which the primary amine(s) on the target biomolecule are ﬁrst modiﬁed by
incubation with a heterobifunctional NHS-HyNic for 30 min at room temperature. Post-modiﬁcation,
excess HyNic is removed with a de-salting spin column and the HyNic-modiﬁed biomolecule is then
added to a solution of 4FB-modiﬁed NCs. Aniline is added as a catalyst for 4FB-HyNic ligation
process [24,25], and the reaction is allowed to proceed for 2 h. The reaction is quenched by the addition
of sulfo-benzaldehyde, and the NC-conjugates are then transferred to a 100 kDa centrifuge ﬁlter, diluted
with 100 mM borate buffer pH 8.4 and buffer exchanged 3 times to remove unreacted antibodies andSensors 2011, 11 10560
catalyst. Finally, puriﬁed conjugates are microcentrifuged brieﬂy at 1,000  g for 5 min to remove any
undissolved solids and cross-linked materials. As the hydrazine and aldehyde reactants are orthogonal
to almost all biological functionalities, they do not alter the subsequent structure or capabilities of other
groups present in the NC-bioconjugate.
Figure 1. Illustration of conjugation reactions. (A) Emission spectra of all 5 NC’s
used in this study; (B) Photograph of the nanocrystals under ultraviolet excitation in
room light. Nanocrystals are composed of CdSe/ZnS and are dispersed into water with a
phospholipid micelle coating; (C) Schematic of the amine-reactive chemistry in which the
lipid-coated nanocrystals have been pre-modiﬁed with 4FB for speciﬁc catalyzed ligation
to a HyNic-modiﬁed antibody; (D) Schematic of the sulfhydryl-reactive chemistry in which
the disulﬁde linkages near the antibody hinge region have been reduced to free sulfhydryl
groups. Conjugation occurs when the sulfhydryl group reacts with an NC surface maleimide
to form a thioether bond. NC and Ab dimensions not necessarily drawn to scale.
Amine-Reactive Chemistry
Modify Biomolecule
Activated Nanocrystal
+
Aniline Catalyst
N
H
O
O
H
Conjugated Nanocrystal
Sulfhydryl-Reactive Chemistry
Conjugated Nanocrystal
N
O
O H
D.
Conjugation to Free
 Sulfhydryl Groups
4FB-Modified Nanocrystal
N
H
O
O
N
H
N
ON
N
Bis-aryl Hydrazone Bond
Thioether Bond
Maleimide-Modified Nanocrystal
O
N
H
N
ON
N
N
O
O
S S
650NC 565NC 605NC 625NC 525NC B.
1.0
0.8
0.6
0.4
0.2
0.0
I
n
t
e
n
s
i
t
y
800 700 600 500 400
Wavelength (nm)
eFluor
®
525NC
eFluor
®
565NC
eFluor
®
605NC
eFluor
®
625NC
eFluor
®
650NC
C.
A.
2.4. Sulfhydryl-Reactive Chemistry
The sulfhydryl-reactive chemistry utilizes a maleimide-activated NC surface coating to target reduced
thiols in the hinge region of antibodies, as diagrammed in Figure 1(D). The NC’s are stored as aSensors 2011, 11 10561
lyophilized powder which includes a proprietary reducing agent. To reconstitute the NC’s, 100 L
of phosphate buffered saline (PBS) pH 7.4 was added, and the mixture warmed in a 60 C water bath
for 30 s or until optically clear. To begin conjugation, 200 g of monoclonal Ab was pipetted directly
into the NC solution and allowed to react for 2 h. At the end of the conjugation reaction, 1 L beta
mercaptoethanol (2-Me) was added and given another 10 minutes to quench any remaining maleimide
groups. The NC-conjugates were then transferred to a 100 kDa centrifuge ﬁlter, diluted with 100 mM
borate buffer pH 8.4 and buffer exchanged 3 times to remove unreacted antibody and 2-Me. The puriﬁed
conjugates were microcentrifuged brieﬂy at 1,000  g for 5 min to remove any undissolved materials
and cross-linked NC’s. Final NC conjugate concentrations were measured using Beer’s Law and the
extinction coefﬁcients given in Table 1.
Table 1. Selected optical properties and details of Ab-NC conjugates used in this study.
Quantum efﬁciency measurements were measured relative to either FITC in absolute ethanol
(eF525NC) or rhodamine 6G in absolute ethanol. Extinction coefﬁcients listed are relative
to the wavelength for the ﬁrst exciton absorption feature [28].
Extinction Coefﬁcient Conjugation Staining
NC PL QY (M 1 cm 1) Antibody Chemistry Concentration
525NC 527 63% 5.57  104 B220 Amine-Reactive 20 nM
565NC 566 60% 1.12  105 PECAM-1 Amine-Reactive 20 nM
605NC 608 64% 2.85  105 CD11b Sulfhydryl-Reactive 5 nM
625NC 628 70% 5.21  105 CD4 Sulfhydryl-Reactive 5 nM
650NC 651 68% 1.12  106 CD11c Sulfhydryl-Reactive 1 nM
2.5. Multicolor Immunohistochemistry
Male C57Bl mice were euthanized using isoﬂurane followed by cervical dislocation using
IACUC-approved protocols. The spleen was removed and placed in ice-cold 1 PBS, pH 7.2, and
rapidly frozen in 2-methyl butane on dry ice for 30 s prior to removing and embedding the spleen in
OCT compound. The spleen was stored at  80 C until sectioning. A 10 m thick section was cut using
a Leica CM3000 cryostat, mounted onto a Superfrost Plus slide, and stored at  80 C.
Prior to staining, sections were allowed to come to room temperature, ﬁxed for 10 min in 100%
acetone, and then gently washed with 1 TBS, pH 7.4. Nonspeciﬁc binding sites within the tissue were
blocked with 1% BSA in TBS for 1 h at room temperature. Experiments were performed to optimize
the concentration of NC-labeled antibodies on sections of spleen after which a cocktail of NC-labeled
antibodies was prepared by diluting each of the NC-labeled antibodies to its predetermined optimal
concentration. The ﬁve NC-labeled antibodies were diluted to the following concentration and combined
in 1% BSA in TBS as follows: eF525-B220/20nM, eF565-PECAM-1/20nM, eF605-CD11b/5nM,
eF625-CD4/5nM, and eF650-CD11c/1nM. Both positive and negative control slides were prepared
using each of the NC-labeled antibodies alone as well as one slide with blocking solution and no
antibodies to serve as an autoﬂuorescence control. The blocking solution was removed from the section,
and the ﬁve-color antibody solution (or single colors) was overlaid and covered lightly with Paraﬁlm
and incubated in the dark at 4 C overnight in a humidiﬁed chamber. Sections were washed withSensors 2011, 11 10562
three changes of 1 PBS and coverslipped with Fluoromount G mounting medium. The edges of the
coverglass were sealed with clear nail polish.
Fluorescence intensity was imaged using an Axiovert 200 microscope equipped with a Nuance EX
spectral imager (CRI). All images were taken using a 20 Plan Apochromat objective and using a
460 nm excitation, 475 nm dichroic, and 500 nm long pass emission ﬁlter. Images were taken from 500
to 750 nm at 10 nm intervals using an exposure time of 50–100 ms. A spectral library was constructed
from the individually stained slides consisting of the representative spectrum of each of the NC’s and
the autoﬂuorescence signal. By assigning a NC to each representative spectrum and subtracting out the
autoﬂuorescence spectrum, the Nuance software was able to differentiate each individual NC signal.
The ﬁve-color slide was then imaged and each NC spectra identiﬁed and assigned a pseudocolor in the
combined image.
3. Results and Discussion
3.1. Chemistry
The proper assembly of a nanoscale material, such as a NC, with a biomolecule for detection purposes
would be optimal with the assembly method that produces the conjugate with the highest and most
desirable activity. “Activity”, in this case, may be deﬁned as fastest reaction rate, highest avidity,
brightest signal, or lowest non-speciﬁc binding, to name a few. Therefore, mounting interest is being
placed on the development of new conjugation chemistries or techniques that may give the researcher
control over the conjugate’s activity by controlling properties such as NC:molecule stoichiometry,
site-selective ligation, or molecular orientation [26] with an emphasis on bioorthogonal ligation
chemistries [27] or chemistries that target rare events within the biomolecule for higher selectivity.
The amine-reactive chemistry described here (Figure 1(C)) is an example of a successful
bioorthogonal chemistry applied to NC-Ab conjugate formation. In this conjugation, the antibody is ﬁrst
modiﬁed with a heterobifunctional crosslinking molecule (NHS-HyNic) that targets the prevalent amine
functionalities found throughout proteins, and presents the bioorthogonal hydrazine moiety outward for
ligation to the 4FB aldehyde on the NC. This reaction is catalyzed by the presence of aniline with
rates between 101 and 103 M 1 s 1 in mildly acidic to neutral conditions [24,25], which has yielded
NC conjugates to monoclonal Ab’s in our laboratories in as short a time as 30 minutes that performed
equivalently to reactions given 2 h. The hydrazine and aldehyde moieties are orthogonal to essentially
all native functionalities found in proteins, and as such will react cleanly only with each other to leave
the rest of the biomolecule relatively undisturbed.
The sulfhydryl-reactive chemistry described in Figure 1(D) describes the exceedingly simple
NC-maleimide reaction to an Ab reduced at the hinge region. Because the presence of sulfhydryl
containing moieties is somewhat rare, their use as a handle in Ab conjugations provides a well-controlled
point of attachment that yields site-selective assembly of these NC-Ab conjugates. The NC’s
have been pre-activated with maleimide functionalities at the extremity of the PEG phospholipid
micelle and then stored with a proprietary co-reducing agent as a lyophilized powder under vacuum.
Although the functionalization of NC’s with a maleimide group for sulfhydryl-ligation has been
accomplished before through the use of heterobifunctional crosslinkers such as succinimidyl-4-(N-Sensors 2011, 11 10563
maleimidomethyl)cyclohexane-1-carboxylate (SMCC) [29,30], these NC’s were modiﬁed immediately
prior to use, and any unutilized NC would have to be discarded due to hydrolysis of the maleimide group.
The maleimide-NC’s described here have been stabilized for at least one year in the lyophilized format
and are available for immediate use with no activation/puriﬁcation steps prior. Also, due to the presence
of a stable reducing agent lyophilized with the NC’s, the conjugation reaction is greatly simpliﬁed to the
basic steps of (1) reconstituting the NC and reducing agent into buffer; (2) adding the biomolecule (must
contain a cysteine, disulﬁde, or equivalent), and ﬁnally (3) puriﬁcation.
We found that likely due to the increased surface area available for conjugation, the larger NC’s
(eF650NC) required a higher Ab:NC ratio of 4, and the smaller NC’s (eF525NC) showed sufﬁcient
conjugate activity at a ratio of only 2. This trend was maintained for both chemistries. It should also
be noted that, while higher Ab ratios may yield better performance with increased avidity, free Ab
may not be sufﬁciently puriﬁed without resorting to the use of more rigorous puriﬁcation methods like
size-exclusion chromatography, that signiﬁcantly increases the time and instrumentation requirements to
produce a conjugate.
3.2. Multiplexed Staining
A comparison of the many different methods used in the literature for the multiplexed staining of
tissue belies the complexity but importance relegated to this portion of the experiment. The highest
successes for multiplexed staining (as determined by the degree of “plexing”) have been reported by
Liu et al. [6] with 4-plex staining, and both our group and Fountaine et al. [3,7] who accomplished
5-plex staining.
Fountaine et al. accomplished 5-plex staining of formalin-ﬁxed parafﬁn embedded (FFPE) tonsil
tissue by designing a sequential staining method whereby ﬁve different streptavidin (SAV)-coated
NC’s were used to do the multiplexing. Their method employed a three-step staining procedure for
each NC in which a primary Ab was incubated ﬁrst, followed by washing then incubation with a
biotinylated secondary Ab, followed by washing and staining with the particular SAV-NC, followed
by an avidin-biotin blocking step before repeating the entire procedure for the next NC. Interestingly,
this research group also reports a three-fold loss in signal intensity when the NC is bound directly to the
secondary antibody in an attempt to eliminate the SAV-Biotin complexing step, which justiﬁed the need
for three incubation steps per NC. The authors do not discuss disassociation kinetics involved with the
multi-layer sandwich assay, but it has been shown that SAV-NC conjugates possess a ten-fold increase
in “off” rate kinetics compared to the native SAV-biotin interaction [31], which would potentially
deteriorate signal and increase the non-speciﬁc background staining because all speciﬁcity in this assay
is based upon SAV-Biotin. Liu et al., on the other hand, were successful in eliminating SAV-Biotin from
the sequential method and streamlining the staining process further.
Liu et al. accomplished 4-plex staining using NC’s conjugated to secondary Ab’s in a semi-sequential
manner to increase throughput of the staining protocol [6]. By ﬁrst incubating the sample with
primary Ab’s of two different isotypes, they were able to perform a 4-plex NC staining of FFPE
tissue with only two sequential rounds of NC-Ab staining where each round consisted of: primary Ab
incubation (2 isotypes), washing steps, NC-Ab secondary isotype speciﬁc staining (2 NC colors stained
simultaneously), then blocking before the second round of NC-Ab staining. Two aspects in particularSensors 2011, 11 10564
set the Liu staining approach apart from earlier efforts: they successfully utilize NC’s conjugated to
secondary antibodies (this attempt produced sub-optimal results for Fountaine et al.), and they negate
concern over disassociation kinetics by cross-linking NC-Ab-antigen complex using common tissue
ﬁxatives. Thus, the efforts of Liu et al. represent a signiﬁcant step forward in allowing multiplexed
staining of NC’s on tissue. Yet, this begs the question: why not assemble the monoclonal Ab directly
onto the NC and skip all subsequent staining steps?
Presumably, the primary reason for research groups to go the route of secondary staining or rely
on SAV-biotin interactions is the commercial availability of NC’s bound to secondary Ab’s or SAV-NC
conjugates. Xing et al. also speculate that direct conjugation to monoclonal Ab’s may deactivate the
Ab binding properties, be negatively impacted by serum or other carrier proteins, and increase costs
because each NC-Ab conjugate may be used against only one marker [17]. If, however, reactive
NC’s were available that made custom NC conjugates to monoclonal Ab’s a feasible option in terms
of time, difﬁculty and price, and the custom conjugates were capable of producing similar results to
either the secondary Ab or SAV-NC conjugates, then the ability to perform multiplexed staining by
cocktail formulation in a single step should be a compelling reason to move toward this approach. By
offering two conjugation chemistries to either the non-targeted but ubiquitous amine functionalities or
the site-speciﬁc and rare sulfhydryl groups, we allow for difﬁculties associated with potential binding
properties to be overcome by the researcher. Also, since the chemistry is easily performed on relatively
small amounts of Ab (200 g Ab, and could likely be scaled down), the cost per experiment is not
unreasonable. Arguments related to interference caused by other proteins should affect secondary Ab
conjugates equally, and in our observations, the inclusion of BSA as a blocking protein in NC conjugates
has not negatively affected our results. When BSA is included in the cocktail we actually observe
improved speciﬁcity and resolution, albeit we have noticed that brightness is affected slightly which is
overcome by a small increase in NC concentration.
To effectively stain all 5 proteins in mouse spleen, matching the appropriate NC with Ab is the ﬁrst
and perhaps the most critical design consideration in a multiplexed experiment. As shown in Table 1, the
extinction coefﬁcients vary greatly from small-to-large NC’s, where the smallest NC’s have the lowest
extinction values, which means that small NC’s like 525NC will absorb and therefore emit far less light
than their larger 650NC counterpart over the same integration time. When matching each NC with an
Ab, the Ab afﬁnity and expected antigen expression levels were taken into account such that the most
prevalent target was matched with the 525NC, and the least prevalent target matched with the largest
650NC. Further, as Table 1 describes, optimal staining concentrations follow a clear trend of decreased
concentration with the larger NC’s, which is a direct ramiﬁcation of the extinction coefﬁcient logic
combined with antigen expression levels to achieve similar ﬂuorescence intensity of all targets. Once
NC-Ab conjugates were designed and the optimal concentration levels determined, a cocktail solution
was mixed and used to stain tissue samples for simple multiplexed detection and imaging.
3.3. Multispectral Imaging
After the challenge of NC-Ab design and direct conjugate incubation has been achieved, detecting and
distinguishing each ﬂuorophore marker becomes the next hurdle due to the possibility of spectral overlap
and autoﬂuorescence complications. Although the use of NC’s for multiplexing has been shown toSensors 2011, 11 10565
substantially alleviate the difﬁculties associated with resolving different ﬂuorescent markers in relatively
clean polymer systems [32], trying to accurately decipher between more than 3 colors in mammalian
tissue amidst a broad spread of background luminescence is difﬁcult and requires a more advanced
optical system and deconvolution software than is bundled with most ﬂuorescence microscopes [33].
A full description of the deconvolution algorithms designed and bundled with multispectral imaging
software is beyond the scope of this paper, but is essentially the mathematical disentangling of different
known spectral proﬁles weighted by their contribution to the total spectrum, i.e., If multiple wavelengths
of light have combined to produce a unique intensity spectrum, those same wavelengths may also be
deconstructed from the total spectrum back to their component parts. This “spectral unmixing” process is
made possible mathematically because emitted light combines linearly to produce a spectrum containing
the sum of all wavelengths and their relative intensities [2]. The caveat is that an understanding of
the individual ﬂuorescence spectra involved must be obtained a priori to performing the multiplexed
experiment through the creation of a spectral library. A spectral library is created by imaging each
ﬂuorophoreindividually(includingunstainedtissuetogaugeautoﬂuorescence)whichwilllaterallowthe
software to recognize the signature spectrum of each ﬂuorophore during the unmixing process. Because
tissue autoﬂuorescence may be considered its own spectral proﬁle, assuming homogeneity across the
tissue sample, then autoﬂuorescence subtraction is as easy as recognizing and subtracting its weighted
contribution across the image.
Figure 2. Autoﬂuorescence subtraction for 605NC-CD11b stained mouse spleen. (A) shows
an image of tissue prior to background subtraction when looking through a microscope
objective. AlthoughNCﬂuorescencemayattimesbevisibleonindividualmacrophagecells,
fully-resolved CD11b+ cells are not distinguishable until after autoﬂuorescence spectral
unmixing and subtraction have taken place; (B) is the resulting ﬂuorescence image after
the autoﬂuorescent background has been eliminated, leaving behind only ﬂuorescence
signal derived from positively-stained 605NC-CD11b macrophage cells in the tissue. Inset:
Example of autoﬂuorescence emission proﬁle (black) and 605NC emission proﬁle (orange)
derived from the tissue sample and used to create the spectral library.
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Figure 2(A) shows a simple single-color stain of mouse spleen using a 605NC-CD11b conjugate
as the image would appear through the objective using typical excitation and emission ﬁlters speciﬁcSensors 2011, 11 10566
to the 605NC. Although a single NC could likely be imaged cleanly by adjusting exposure time, this
image shows the prevalence of autoﬂuorescence and the difﬁculty discerning positively-stained cells.
Figure 2(B) shows the same image after applying the appropriate library (ﬁgure inset) to spectrally
unmix the 605NC and autoﬂuorescence signals. Clearly, multispectral imaging combined with unmixing
algorithms are powerful tools for detecting and deciphering speciﬁc ﬂuorescence signals out of the
autoﬂuorescent milieu. We refer the interested reader to several articles on the use of spectral imaging
and spectral unmixing [1,2,34,35].
Figure 3. (A) Five-color multiplexed image (psuedo-colored composite) of mouse spleen
after staining with NC monoclonal Ab direct conjugates, imaging with the CRI Nuance
multispectral imager, and spectral unmixing to remove autoﬂuorescence; (B) Individual
NC ﬂuorescence signals resulting from spectral unmixing. Each of the individual images
is assigned a pseudo-color (autoﬂuorescence is assigned black) and overlaid to form the
composite image above. The conjugate/color scheme is as follows: 525NC-B220/blue,
565NC-PECAM-1/yellow, 605NC-CD11b/aqua, 625NC-CD4/green, 650NC-CD11c/red.
525NC-B220 565NC-PECAM-1 605NC-CD11b
625NC-CD4 650NC-CD11c Autofluorescence
A.
B.Sensors 2011, 11 10567
As a ﬁnal test of the abilities of the NC-Ab direct conjugates to stain their individual targets from
a cocktail formulation and utilizing the multispectral imager to effectively unmix all ﬂuorescence
wavelengths, we performed a 5-plex staining of mouse spleen tissue. Figure 3(A) shows a representative
composite image of 5-color multiplexed staining after spectral unmixing and autoﬂuorescence removal.
In this image, the structure/function relationship of multiple immune cell types is shown with the use
of 5-color staining. The 525NC-B220 conjugate (blue) highlights a B-cell center, which is closely
associated with leukocyte and endothelial cells stained by 565NC-PECAM-1 (yellow). PECAM-1
(CD31) is a surface protein expressed on all leukocyte and endothelial cells in low levels, and functions
in cell-cell adhesion and signal transduction. The 605NC-CD11b conjugate (aqua) targets macrophage
cells which express integrin M, and the 625NC-CD4 conjugate (green) targets the CD4 molecule
which is expressed by the majority of thymocytes found in the mouse spleen. The 650NC-CD11c
conjugate (red) is speciﬁc for integrin protein X found on activated T cells and dendritic cells, and
appears as individual cells either surrounding the B cells or throughout the tissue. Because very little
co-localization of multiple NC wavelengths appears in the ﬁnal image, this suggests that each NC-Ab
conjugate was speciﬁc for each particular surface marker. Although in this experiment the usage of a
particular chemistry to produce each conjugate was random, the matching of each NC with an Ab for
conjugation was decided based on expected expression levels and NC extinction coefﬁcients as discussed
previously. Designing the conjugates in this manner allowed us to achieve similar brightness levels for
each marker.
Figure 3(B) shows the unmixed spectra speciﬁc to each emission proﬁle (including autoﬂuorescence)
which have been recombined to form the composite 5-color image found in part A. In the single-color
images, each marker is delineated from all of the other NC wavelengths present, further demonstrating
the utility of multispectral imaging when multiple ﬂuorescent markers are involved. Indeed, no
co-localization was expected because each NC-Ab conjugate was directed at a speciﬁc cell type.
However, the clear ability to image each NC conjugate separately suggests that studies requiring
co-localization of markers may work equally well, paving the way for the elucidation of cell-cell and
even protein-protein interactions in future studies.
4. Conclusions
The studies described here detail two novel conjugation chemistries allowing for the rapid and facile
attachment of nanocrystals to biological molecules using either ubiquitous amine groups found on most
biomolecules for general attachment strategies, or less common sulfhydryl moieties for more targeted
attachment. Both chemistries are used to conjugate ﬁve separate NC’s to 200 g each of ﬁve different
monoclonal antibodies using simple conjugation and puriﬁcation protocols. The conjugates were tested
individually to stain mouse spleen tissue and a spectral library was created for spectral unmixing by the
multispectral imager. A cocktail formulation was mixed which contained each of the NC conjugates at
its optimized concentration, and the cocktail was used for direct staining of mouse spleen tissue. An
epiﬂuorescence microscope with multispectral imager attachment was used to view and photograph
the slides, and spectral unmixing by the supplied software showed that the system was capable of
not only resolving each NC-Ab conjugate from neighboring emission spectra, but also simultaneously
removing background autoﬂuorescence to produce a meaningful image of cellular patterns whereSensors 2011, 11 10568
each cell was identiﬁed by cell type and location. The combination of narrow emission spectra and
unique conjugation chemistry provided by the NC’s, with multispectral imaging, spectral unmixing and
background autoﬂuorescence subtraction demonstrates the clear potential that these technologies may
bring to pathology and diagnostics research.
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